Age at Growth Hormone Therapy Start and First-Year Responsiveness to Growth Hormone Are Major Determinants of Height Outcome in Idiopathic Short Stature

Publisher： Karger

E-ISSN： 1663-2826|68|2|53-62

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.68, Iss.2, 2007-01, pp. : 53-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Height at Start, First-Year Growth Response and Cause of Shortness at Birth Are Major Determinants of Adult Height Outcomes of Short Children Born Small for Gestational Age and Silver-Russell Syndrome Treated with Growth Hormone: Analysis of Data from KIGS

By  

Hormone Research in Paediatrics, Vol. 74, Iss. 4, 2010-04 ,pp. : 259-266

Karger

Access to resources Recommend Favorite

Determinants of Short Stature and the Response to Growth Hormone Therapy

By  

Hormone Research in Paediatrics, Vol. 71, Iss. 2, 2009-04 ,pp. : 2-4

Karger

Access to resources Recommend Favorite

Bone Age Progression during the First Year of Growth Hormone Therapy in Pre-Pubertal Children with Idiopathic Growth Hormone Deficiency, Turner Syndrome or Idiopathic Short Stature, and in Short Children Born Small for Gestational Age: Analysis of Data from KIGS (Pfizer International Growth Database)

By  

Hormone Research in Paediatrics, Vol. 63, Iss. 1, 2005-01 ,pp. : 40-47

Karger

Access to resources Recommend Favorite

Growth Outcomes in Individuals with Idiopathic Short Stature Treated with Growth Hormone Therapy

By  

Hormone Research in Paediatrics, Vol. 76, Iss. 3, 2011-09 ,pp. : 42-45

Karger

Access to resources Recommend Favorite

Metabolic Benefits of Growth Hormone Therapy in Idiopathic Short Stature

By  

Hormone Research in Paediatrics, Vol. 76, Iss. 3, 2011-09 ,pp. : 56-58

Karger

Access to resources Recommend Favorite